Camosunate Powder 1-6yrs

Camosunate is an oral antimalarial medication containing two active ingredients in powder form: Amodiaquine base (150 mg) and Artesunate (50 mg). It is an Artemisinin-based Combination Therapy (ACT) specifically formulated for children aged 1–6 years. It is primarily used for the treatment of uncomplicated malaria caused by the Plasmodium falciparum parasite.

As an ACT, it works through a dual mechanism: Artesunate quickly reduces the number of parasites in the blood during the first few days of treatment, while Amodiaquine, a longer-acting medication, eliminates the remaining parasites. This combination helps to provide a rapid cure and reduce the development of drug resistance.

Key Benefits:

– Targeted Pediatric Formulation (Ages 1–6 Years)

– Highly Effective ACT Combination

– Rapid Parasite Clearance

– Convenient Powder Form for Oral Administration

CAUTION: This medication must be used exactly as prescribed by a healthcare professional. Complete the full course of treatment even if the child feels better to ensure all parasites are cleared. Side effects may include nausea, abdominal pain, or fatigue. Seek immediate medical attention if the child’s condition worsens or if they develop a severe skin rash or yellowing of the eyes.